Oxford Nanopore at InSiGHT 2026
)
Overview
Oxford Nanopore are sponsoring, exhibiting and presenting at 11th Biennial Meeting of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT 2026). The event brings together clinicians, researchers, geneticists, nurses, policy makers and other healthcare professionals with a shared focus on hereditary conditions that predispose individuals to gastrointestinal tumours, such as Lynch syndrome and Familial Adenomatous Polyposis.
Details for the Oxford Nanopore Symposium Session below.
Please also visit us and join our symposium session if you are able to attend the conference.
Symposium Session
Details to follow
Date: Friday, 5th March 2026
Time: 15:40 - 16:10 SST
Location: Laguna Ballroom, Dusit Thani Laguna Singapore
Reveal more cancer biology with ultra-rich Oxford Nanopore sequencing data
In this session, you will learn about Oxford Nanopore hereditary cancer panel, enabled through adaptive sampling, a real-time, on-device enrichment method unique to Oxford Nanopore sequencing. How it enables comprehensive detection of single nucleotide variants (SNVs), insertions/deletions (indels), SVs, pseudogenes, repetitive regions, direct methylation profiling, alongside low-pass whole-genome coverage to enable copy number variant detection in a flexible workflow to characterize variants in hereditary cancer susceptibility genes. You will hear real world performance of the panel, its efficiency and variant detection accuracy, and how laboratories can achieve faster, more cost-effective, and comprehensive genetic insights to support precision oncology.
Symposium Speaker
)
Manop Pithukpakorn, Mahidol UniversityDr. Manop Pithukpakorn is an internist, clinical and molecular geneticist. He is currently a Professor of Medicine at the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. Dr. Pithukpakorn received his medical degree from the Faculty of Medicine Siriraj Hospital, Mahidol University, residency training in Internal Medicine from the University of Illinois Chicago, and fellowship in Clinical Genetics and Molecular Genetics from the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), USA. Dr. Pithukpakorn’s current research projects are genomic investigations in various Mendelian disorders and Thailand Cancer Precision Medicine;by utilizing genome sequencing technology, computational analysis, systems biology and high-throughput drug screening for comprehensive studies of various cancers in Thai population. Genomics Thailand Initiative is the first inter-ministerial project aiming to implement genomic medicine into national healthcare system and build a population-level genome database. The project will utilize genome sequencing and other genome technology for healthcare service in 5 main areas including cancers, rare diseases, pharmacogenomics, infectious diseases and non-communicable diseases. Dr. Pithukpakorn is the initiative's head of research and development working group and is overseeing cancer program of Genomics Thailand.
